What is a stock summary page? Click here for an overview.
Business Description
Hepion Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US21234W2026
Description
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.67 | |||||
| Equity-to-Asset | -0.11 | |||||
| Debt-to-Equity | -5.46 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 32.5 | |||||
| 3-Year EPS without NRI Growth Rate | 35.3 | |||||
| 3-Year FCF Growth Rate | 31.7 | |||||
| 3-Year Book Growth Rate | -63.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.92 | |||||
| 9-Day RSI | 14.43 | |||||
| 14-Day RSI | 20.76 | |||||
| 3-1 Month Momentum % | -67.37 | |||||
| 6-1 Month Momentum % | -74.91 | |||||
| 12-1 Month Momentum % | -93.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | |||||
| Quick Ratio | 1.3 | |||||
| Cash Ratio | 0.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -44.2 | |||||
| Shareholder Yield % | -60.67 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -332.76 | |||||
| ROA % | -164.98 | |||||
| ROIC % | -947.24 | |||||
| 3-Year ROIIC % | 476.68 | |||||
| ROC (Joel Greenblatt) % | -1964.39 | |||||
| ROCE % | -295.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.11 | |||||
| EV-to-EBITDA | -0.11 | |||||
| EV-to-FCF | -0.13 | |||||
| Earnings Yield (Greenblatt) % | -909.09 | |||||
| FCF Yield % | -3254.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HEPA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hepion Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -219 | ||
| Beta | 2.09 | ||
| 3-Year Sharpe Ratio | -0.91 | ||
| 3-Year Sortino Ratio | -1.36 | ||
| Volatility % | 68.26 | ||
| 14-Day RSI | 20.76 | ||
| 14-Day ATR ($) | 0.941258 | ||
| 20-Day SMA ($) | 3.546645 | ||
| 12-1 Month Momentum % | -93.06 | ||
| 52-Week Range ($) | 0.671 - 144.995 | ||
| Shares Outstanding (Mil) | 1.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hepion Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hepion Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hepion Pharmaceuticals Inc Frequently Asked Questions
What is Hepion Pharmaceuticals Inc(HEPA)'s stock price today?
The current price of HEPA is $0.74. The 52 week high of HEPA is $145.00 and 52 week low is $0.67.
When is next earnings date of Hepion Pharmaceuticals Inc(HEPA)?
The next earnings date of Hepion Pharmaceuticals Inc(HEPA) is 2025-05-21 Est..
Does Hepion Pharmaceuticals Inc(HEPA) pay dividends? If so, how much?
Hepion Pharmaceuticals Inc(HEPA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers